STAFFORD, Texas, Jan. 23, 2025 (GLOBE NEWSWIRE) — Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the “Company”), a clinical-stage biopharmaceutical company focused…
World’s leading pet healthcare provider highlights global progress in three key areas: addressing climate change, reducing waste, and promoting pharmaceutical…